The National Comprehensive Cancer Network® (NCCN®)—a nonprofit responsible for globally utilized guidelines for cancer care—shares new NCCN Guidelines Navigator™ resources for breast cancer treatment ...

Panelists discuss how current NCCN guidelines emphasize the importance of treating AML at experienced centers with proper ...

Today, the National Comprehensive Cancer Network® (NCCN®)-a nonprofit responsible for globally utilized guidelines for cancer care-is sharing new NCCN Guidelines Navigator™ resources for breast cancer ...

The National Comprehensive Cancer Network expands interactive library of evidence-based, expert consensus-driven cancer care guidance to now cover treatment for more than a dozen cancer types, along ...

New research published online in the Journal of the National Comprehensive Cancer Network finds that people with cancer who ...

Bouchard opened a discussion on sequencing therapies in MM, noting that CAR T-cell therapy and bispecific antibodies each ...

EMA committee recommends marketing approval for Novartis’ Scemblix to treat adults with newly diagnosed CML: Basel Monday, October 20, 2025, 11:00 Hrs [IST] Novartis announced t ...

Syndax has submitted a supplemental New Drug Application/sNDA seeking approval for revumenib to treat R/R mNPM1 AML. The US FDA granted the sNDA Priority Review and is reviewing it under the Real-Time ...

Petros Grivas, MD, PhD, discusses the overall survival and quality-of-life findings from the JAVELIN Bladder 100 trial of ...

Chandler H. Park, MD, a medical oncologist at Norton Cancer Institute and advisory dean/professor at University of Louisville in Kentucky, discusses the Category 1 treatment options for metastatic ...

Two physicians at the UNC Health system have been elected to the National Academy of Medicine, officials said Monday.